Pharmaceutical

MRNA-1365 by Moderna for Human Metapneumovirus Infections: Likelihood of Approval

MRNA-1365 is under clinical development by Moderna and currently in Phase I for Human Metapneumovirus Infections.

May 17, 2024 - 04:00
MRNA-1365 is under clinical development by Moderna and currently in Phase I for Human Metapneumovirus Infections.
Read the original article

Tags:

Previous Article

TT-01488 by TransThera Sciences (Nanjing) for Mantle Cell Lymphoma: Likelihood o...

Next Article

LY-3541860 by Eli Lilly and Co for Relapsing Multiple Sclerosis (RMS): Likelihoo...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: I finally got used to practicing telepsychiatry. Now the DEA wants to change everything

Opinion: I finally got used to practicing telepsychiatr...

Mar 24, 2023

STAT+: From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity

STAT+: From a small town in Wales, a scientific sleuth ...

Jan 28, 2024

Opinion: Insurance companies are forcing psychiatrists like me to stop accepting their coverage

Opinion: Insurance companies are forcing psychiatrists ...

Jan 4, 2024